novartis - dofaq.co
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Business Wire - 30 Apr 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis ...
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ...
Medicines for Malaria Venture - 24 Apr 2024
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ... ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
FiercePharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Novartis in Society Integrated Report
Novartis - 31 Jan 2024
Novartis in Society Integrated Report ...
NICE recommends Novartis precision brain cancer treatment
European Pharmaceutical Review - 24 Apr 2024
NICE recommends Novartis precision brain cancer treatment ...
Deciphex partners with Novartis for AI drug research
SiliconRepublic.com - 29 Apr 2024
Deciphex partners with Novartis for AI drug research ...
Novartis reports 25% increase in net income in Q1 2024
Pharmaceutical Technology - 24 Apr 2024
Novartis reports 25% increase in net income in Q1 2024 ...
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM - 24 Apr 2024
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes ...
Novartis Raises Forecast as Sales of New Blockbuster Medicines Climb
Bloomberg - 23 Apr 2024
Novartis Raises Forecast as Sales of New Blockbuster Medicines Climb ...
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO
FiercePharma - 23 Apr 2024
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO ...
Novartis accused of promoting asthma drug for preterm labor despite brain risk
Reuters - 23 Apr 2024
Novartis accused of promoting asthma drug for preterm labor despite brain risk ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
Novartis bags paediatric FDA label expansion for Lutathera
Pharmaceutical Technology - 24 Apr 2024
Novartis bags paediatric FDA label expansion for Lutathera ...
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs
FiercePharma - 23 Apr 2024
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs ...
Novartis raises guidance after beating Q1 expectations
Reuters - 23 Apr 2024
Novartis raises guidance after beating Q1 expectations ...